Simon Chivers
Impact in
- Small Animals top 5%
- Animal testing and alternatives
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Biosimilars and Bioanalytical Methods 2
- Toxin Mechanisms and Immunotoxins 1
- Co-authors
- Francesca Zammarchi (7 shared papers)Patrick H. van Berkel (6 shared papers)Philip W. Howard (5 shared papers)Lauren R. Adams (5 shared papers)David Gareth Williams (4 shared papers)Simon Corbett (5 shared papers)John Anthony Hartley (5 shared papers)Arnaud C. Tiberghien (2 shared papers)
- Journals
- Blood (3 papers)Molecular Cancer Therapeutics (2 papers)Journal of Clinical Investigation (1 paper)Regulatory Toxicology and Pharmacology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United KingdomSwitzerlandGermany
In The Last Decade
Simon Chivers
15 papers receiving 644 citations
Peers
Comparison fields: 5 of 51
- Small Animals 85
- Radiology, Nuclear Medicine and Imaging 166
- Immunology 115
- Pathology and Forensic Medicine 95
- Oncology 108
Countries citing papers authored by Simon Chivers
This map shows the geographic impact of Simon Chivers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Chivers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Chivers more than expected).
Fields of papers citing papers by Simon Chivers
This network shows the impact of papers produced by Simon Chivers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Chivers. The network helps show where Simon Chivers may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Chivers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 152 | |
| 2 | 2018 | 110 | |
| 3 | 2020 | 70 | |
| 4 | 2014 | 63 | |
| 5 | 2017 | 60 | |
| 6 | 2009 | 58 | |
| 7 | 2013 | 44 | |
| 8 | 2018 | 41 | |
| 9 | 2016 | 17 | |
| 10 | 2016 | 15 | |
| 11 | 2016 | 12 | |
| 12 | 2016 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2015 | 10 | |
| 15 | 2024 | 10 |
About Simon Chivers
Simon Chivers is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Organic Chemistry, Oncology and Small Animals, having authored 15 papers that have together received 684 indexed citations. Recurring topics across this work include Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (2 papers), Biosimilars and Bioanalytical Methods (2 papers), RNA Interference and Gene Delivery (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Bone health and osteoporosis research (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Small Animals (85 citations), Radiology, Nuclear Medicine and Imaging (166 citations), Immunology (115 citations), Pathology and Forensic Medicine (95 citations) and Oncology (108 citations). Simon Chivers has collaborated with scholars based in United Kingdom, Switzerland and Germany. Frequent co-authors include Francesca Zammarchi, Patrick H. van Berkel, Philip W. Howard, Lauren R. Adams, David Gareth Williams, Simon Corbett, John Anthony Hartley, Arnaud C. Tiberghien, Carin E.G. Havenith and Karin Havenith. Their work appears in journals such as Blood, Molecular Cancer Therapeutics, Journal of Clinical Investigation, Regulatory Toxicology and Pharmacology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.